Condition
Pseudophakic Bullous Keratopathy clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Pseudophakic Bullous Keratopathy clinical trials that are recruiting, at sites in 6 countries (most in United States (2), France (1), Mexico (1)). By phase: Phase 1 (2), Phase 2 (1), Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 6Countries
Newest Pseudophakic Bullous Keratopathy clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| EO2002 therapy for corneal edema due to endothelial dysfunction | Phase 2 | Torrance, California and 9 other locations | Recruiting | Jul 27, 2026 |
| PVEK corneal implant to treat corneal swelling | Phase 1 | Yerevan and 2 other locations | Recruiting | Jan 8, 2026 |
| Observing outcomes of posterior lamellar keratoplasty for eye conditions | — | Metz | Recruiting | Mar 5, 2025 |
| OPTIMISE — safer steroid plans after DMEK cornea transplant | Phase 4 | Apeldoorn, Gelderland and 7 other locations | Recruiting | Feb 8, 2023 |
| Assessing the safety of EO2002 injections for corneal conditions | Phase 1 | Mexico City, Mexico City | Recruiting | Dec 5, 2022 |
| Using OCT to assess corneal health in Fuchs' Dystrophy | — | Portland, Oregon | Recruiting | Feb 6, 2020 |
All recruiting trials (6)
-
EO2002 therapy for corneal edema due to endothelial dysfunction
This trial tests whether a single intracameral injection of EO2002 cells can improve vision and reduce corneal thickness in adults with corneal edema from endothelial dysfunction.
-
PVEK corneal implant to treat corneal swelling
This study will test a PVEK tissue‑engineered corneal implant to see if it is safe and helps people with corneal swelling from Fuchs' endothelial dystrophy or pseudophakic bullous keratopathy who need endothelial keratoplasty.
-
Observing outcomes of posterior lamellar keratoplasty for eye conditions
This study looks at how well two types of eye surgeries for conditions like Fuchs' dystrophy and bullous keratopathy work in helping patients see better over time.
-
OPTIMISE — safer steroid plans after DMEK cornea transplant
This study tests whether using a milder steroid eye drop plan or stopping steroids earlier after DMEK can still prevent graft rejection while reducing the risk of high eye pressure in adults receiving corneal transplants.
-
Assessing the safety of EO2002 injections for corneal conditions
This study is testing if EO2002 injections are safe for people with corneal conditions like Fuchs' dystrophy or pseudophakic bullous keratopathy.
-
Using OCT to assess corneal health in Fuchs' Dystrophy
This study is testing a new way to measure corneal swelling in people with Fuchs' dystrophy to see how it affects their vision after surgery.
Related topics
Quick answers
How many Pseudophakic Bullous Keratopathy clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 6 countries. The most sites are in United States (2 trials), France (1 trial), Mexico (1 trial), Armenia (1 trial), Israel (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2, Phase 2: 1, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.